TY - JOUR
T1 - Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions
AU - Jönsson, Peter
AU - Southcombe, Jennifer H
AU - Santos, Ana Mafalda
AU - Huo, Jiandong
AU - Fernandes, Ricardo A
AU - McColl, James
AU - Lever, Melissa
AU - Evans, Edward J
AU - Hudson, Alexander
AU - Chang, Veronica T
AU - Hanke, Tomáš
AU - Godkin, Andrew
AU - Dunne, Paul D
AU - Horrocks, Mathew H
AU - Palayret, Matthieu
AU - Screaton, Gavin R
AU - Petersen, Jan
AU - Rossjohn, Jamie
AU - Fugger, Lars
AU - Dushek, Omer
AU - Xu, Xiao-Ning
AU - Davis, Simon J
AU - Klenerman, David
PY - 2016/5/17
Y1 - 2016/5/17
N2 - The αβ T-cell coreceptor CD4 enhances immune responses more than 1 million-fold in some assays, and yet the affinity of CD4 for its ligand, peptide-major histocompatibility class II (pMHC II) on antigen-presenting cells, is so weak that it was previously unquantifiable. Here, we report that a soluble form of CD4 failed to bind detectably to pMHC II in surface plasmon resonance-based assays, establishing a new upper limit for the solution affinity at 2.5 mM. However, when presented multivalently on magnetic beads, soluble CD4 bound pMHC II-expressing B cells, confirming that it is active and allowing mapping of the native coreceptor binding site on pMHC II. Whereas binding was undetectable in solution, the affinity of the CD4/pMHC II interaction could be measured in 2D using CD4- and adhesion molecule-functionalized, supported lipid bilayers, yielding a 2D Kd of ∼5,000 molecules/μm(2) This value is two to three orders of magnitude higher than previously measured 2D Kd values for interacting leukocyte surface proteins. Calculations indicated, however, that CD4/pMHC II binding would increase rates of T-cell receptor (TCR) complex phosphorylation by threefold via the recruitment of Lck, with only a small, 2-20% increase in the effective affinity of the TCR for pMHC II. The affinity of CD4/pMHC II therefore seems to be set at a value that increases T-cell sensitivity by enhancing phosphorylation, without compromising ligand discrimination.
AB - The αβ T-cell coreceptor CD4 enhances immune responses more than 1 million-fold in some assays, and yet the affinity of CD4 for its ligand, peptide-major histocompatibility class II (pMHC II) on antigen-presenting cells, is so weak that it was previously unquantifiable. Here, we report that a soluble form of CD4 failed to bind detectably to pMHC II in surface plasmon resonance-based assays, establishing a new upper limit for the solution affinity at 2.5 mM. However, when presented multivalently on magnetic beads, soluble CD4 bound pMHC II-expressing B cells, confirming that it is active and allowing mapping of the native coreceptor binding site on pMHC II. Whereas binding was undetectable in solution, the affinity of the CD4/pMHC II interaction could be measured in 2D using CD4- and adhesion molecule-functionalized, supported lipid bilayers, yielding a 2D Kd of ∼5,000 molecules/μm(2) This value is two to three orders of magnitude higher than previously measured 2D Kd values for interacting leukocyte surface proteins. Calculations indicated, however, that CD4/pMHC II binding would increase rates of T-cell receptor (TCR) complex phosphorylation by threefold via the recruitment of Lck, with only a small, 2-20% increase in the effective affinity of the TCR for pMHC II. The affinity of CD4/pMHC II therefore seems to be set at a value that increases T-cell sensitivity by enhancing phosphorylation, without compromising ligand discrimination.
KW - Adhesion
KW - Binding equilibrium and kinetics
KW - Protein interactions
KW - T-cell activation
KW - TCR phosphorylation
UR - http://www.scopus.com/inward/record.url?scp=84969786276&partnerID=8YFLogxK
U2 - 10.1073/pnas.1513918113
DO - 10.1073/pnas.1513918113
M3 - Journal article
C2 - 27114505
SN - 0027-8424
VL - 113
SP - 5682
EP - 5687
JO - Proceedings of the National Academy of Sciences
JF - Proceedings of the National Academy of Sciences
IS - 20
ER -